meddevicedb.com FDA Device Reference

ACTIVATED ASPARTATE AMINOTRANSFERASE

K071525 Class II Traditional
Decision Date
2008-03-19
Sponsor / Applicant
Abbott Laboratories

Technical Specification

510(k) Submission ID K071525
Product Code CIT
Medical Specialty / Panel Clinical Chemistry
Regulation Citation 21 CFR 862.1100
Decision Date 2008-03-19
Clearance Pathway Traditional

Official Documentation

FDA CDRH Summary / statement of record

View FDA Summary PDF

Clearance Summary

ACTIVATED ASPARTATE AMINOTRANSFERASE received FDA 510(k) clearance under submission number K071525, sponsored by Abbott Laboratories. The device was reviewed via the Traditional premarket notification pathway and assigned to the Clinical Chemistry review panel. The statutory decision date of record is 2008-03-19.

Classification & Regulation

This clearance is catalogued under FDA product code CIT and 21 CFR 862.1100, within the Clinical Chemistry review panel as a Class II device.